कृपया अन्य खोज का प्रयास करें
चिन्ह | एक्सचेंज | करेंसी | ||
---|---|---|---|---|
CALTX | स्टॉकहोल्म | SEK | रियल टाइम | |
CALTXs | BATS Europe | SEK | देरी | |
CALT | NASDAQ | USD | रियल टाइम |
Calliditas Therapeutics AB (publ), a commercial-stage bio-pharmaceutical company, focused on identifying, developing, and commercializing novel treatments in orphan indications with an initial focus on renal and hepatic diseases with significant unmet medical needs in the United States, Europe, and Asia. It offers Nefecon (TARPEYO/Kinpeygo), an oral formulation of budesonide to reduce the loss of kidney function in adults with immunoglobulin A nephropathy. The company’s lead compound is Setanaxib, a NOX inhibitor that is in Phase 2b clinical trial for the treatment of primary biliary cholangitis; and in Phase 2 clinical trial for the treatment of squamous cell carcinoma of the head and neck cancer and idiopathic pulmonary fibrosis, as well as for solid tumors and Alport Syndrome. Calliditas Therapeutics AB (publ) was incorporated in 2004 and is headquartered in Stockholm, Sweden.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Elmar J. Schnee | 63 | 2019 | Independent Chairman |
Vladimir Tesar | - | - | Member of Scientific Advisory Board |
Hérnan Trimarchi | - | - | Member of Scientific Advisory Board |
Brad H. Rovin | - | - | Member of Scientific Advisory Board |
Jürgen Floege | - | - | Member of Scientific Advisory Board |
Jonathan Barratt | - | - | Member of Scientific Advisory Board |
Richard Lafayette | - | - | Member of Scientific Advisory Board |
Hilde Furberg | 65 | 2014 | Independent Non-Executive Director |
Elisabeth Bjork | 62 | 2022 | Independent Director |
Hong Zhang | - | - | Member of Scientific Advisory Board |
Heather N. Reich | - | - | Member of Scientific Advisory Board |
Diane L. Parks | 72 | 2019 | Independent Non-Executive Director |
Henrik Stenqvist | 57 | 2022 | Independent Non-Executive Director |
Frederick W. Driscoll | 73 | 2023 | Independent Non-Executive Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है